DUBLIN--(BUSINESS WIRE)--The "Datapack - Pharmaprojects Pharma R&D Annual Review 2017" report has been added to Research and Markets' offering.
Stay informed on industry R&D trends and perform your own in-depth analysis. This datapack presents the supporting data from our seminal white paper, Pharmaprojects Pharma R&D Annual Review 2017. Over the past 25 years, the pharma R&D sector has seen many twists and turns.
Included with your purchase, our white paper looks at developments in a year that saw some new players make the big time, while others hit skid row after one too many negative (clinical) reviews. Sourced from Pharmaprojects, the industry's most trusted clinical drug development database, the information included in this datapack covers multiple views of the R&D pipeline by company, development phase, therapy area, and more, allowing you to perform your own analysis and dive deeper into the underlying data.
Disease Group Covered:
- Allergy
- Autoimmune/immunology
- Cardiovascular
- Dermatology
- Endocrine
- Gastroenterology (non inflammatory bowel disease)
- Hematology
- Infectious disease
- Metabolic
- Neurology
- Not Specified
- Obstetrics/Gynecology
- Oncology
- Ophthalmology
- Orthopedics
- Psychiatry
- Renal
- Respiratory
- Rheumatology (non autoimmune)
- Urology
For more information about this report visit https://www.researchandmarkets.com/research/7p374n/datapack
